Carlos Becerra, MD

Trials

Studies that name Carlos Becerra, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:02 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT07344220 · Metastatic Non-Familial Adenocarcinoma Maintenance Therapy With DZ-002: Heptamine Carboxymethine Dye Conjugate

  Hoag Memorial Hospital Presbyterian · enrolling by invitation · Metastatic Pancreatic Adenocarcinoma, Pancreatic Cancer · principal investigator
• Ph1
  NCT04878484 · Evaluate TCRT-ESO-A2 Autologous T Cells Expressing TCR Specific for NY-ESO-1 in Subjects With Advanced Solid Tumors

  Athenex, Inc. · withdrawn · Advanced Solid Tumor · principal investigator
• Early Ph1
  NCT02550327 · Gemcitabine, Nab-Paclitaxel, Cisplatin and Anakinra Treatment on Patients With Pancreatic Cancer

  Baylor Research Institute · completed · Pancreatic Adenocarcinoma · principal investigator
• Ph1
  NCT02548169 · Dendritic Cell Vaccine and Chemotherapy for Patients With Pancreatic Cancer

  Baylor Research Institute · terminated · Pancreatic Cancer · principal investigator
• Ph1
  NCT02021422 · A Pilot, Prospective, Non-randomized Evaluation of the Safety of Anakinra Plus Standard Chemotherapy

  Baylor Research Institute · completed · Pancreas Cancer · principal investigator
• Ph1
  NCT01837667 · Phase I Study of LB-100 With Docetaxel in Solid Tumors

  Lixte Biotechnology Holdings, Inc. · completed · Tumors, Neoplasms, Cancer · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 13:02 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 3 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.